← Back to Search

Educational Videos for Cancer Communication

Led By Rebecca Pentz, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Screening 3 weeks
Treatment Varies
Follow Up up to 4 years
Awards & highlights

Study Summary

This trial looks at how patients & providers communicate about immunotherapy & how educational videos can improve patient understanding.

Who is the study for?
This trial is for patients and healthcare providers at the Winship Cancer Institute who may discuss immunotherapy. It's also open to any cancer patient interested in how educational videos can help understand immunotherapy.Check my eligibility
What is being tested?
The study looks at communication issues during discussions about immunotherapy between patients and providers. It aims to find out where patients learn about it, their understanding, how healthcare workers explain it, and if videos improve patient knowledge.See study design
What are the potential side effects?
Since this trial involves educational materials like videos and interviews rather than medical treatments, there are no direct physical side effects associated with participating.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 4 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Correct definition rates (pre- versus post-video)
Misestimations about the risks and benefits of immunotherapy resulting from media hype or other sources
Provider and patient preferences for information to be communicated about immunotherapy
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: InterviewExperimental Treatment2 Interventions
Patients and providers undergo observation during a conversation about immunotherapy. Then participate in an interview over 20 minutes.
Group II: Aim 4 tests an educational videoExperimental Treatment1 Intervention
The participants watch a video and their comprehension is tested in a pre and post methodology

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,636 Previous Clinical Trials
2,560,448 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,028 Total Patients Enrolled
1 Trials studying Blood Cancers
70 Patients Enrolled for Blood Cancers
Rebecca Pentz, PhDPrincipal InvestigatorEmory University Hospital/Winship Cancer Institute
1 Previous Clinical Trials
100 Total Patients Enrolled

Media Library

Interview Clinical Trial Eligibility Overview. Trial Name: NCT05873608 — N/A
Blood Cancers Research Study Groups: Interview, Aim 4 tests an educational video
Blood Cancers Clinical Trial 2023: Interview Highlights & Side Effects. Trial Name: NCT05873608 — N/A
Interview 2023 Treatment Timeline for Medical Study. Trial Name: NCT05873608 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial presently enrolling participants?

"Affirmative, the information hosted on clinicaltrials.gov affirms that this medical trial is presently recruiting applicants. Initially posted on October 6th 2016 and last amended on June 5th 2023, the research requires 125 participants from 2 distinct sites."

Answered by AI

What is the cap on participant numbers in this clinical experiment?

"Affirmative. According to the clinicaltrials.gov repository, this trial is presently recruiting subjects and was initially posted on October 6th 2016; it has been recently amended on June 5th 2023. 125 volunteers need to be recruited from two separate locations."

Answered by AI
~16 spots leftby Jun 2025